Schonfeld Strategic Advisors LLC Syndax Pharmaceuticals Inc Transaction History

Schonfeld Strategic Advisors LLC

$13.8 Billion
Q3 2024

A detailed history of Schonfeld Strategic Advisors LLC transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 187,463 shares of SNDX stock, worth $3.02 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

187,463

Previous 260,876 28.14%

Holding current value

$3.02 Million

Previous $5.36 Million 32.62%

% of portfolio

0.03%

Previous 0.04%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$17.93 - $24.81 $1.32 Million - $1.82 Million	-73,413 Reduced 28.14%	187,463 $3.61 Million
Q2 2024 Aug 14, 2024	SELL	$18.82 - $23.79 $9.88 Million - $12.5 Million	-524,768 Reduced 66.79%	260,876 $5.36 Million
Q1 2024 May 15, 2024	BUY	$19.71 - $24.57 $6.19 Million - $7.72 Million	314,169 Added 66.64%	785,644 $18.7 Million
Q4 2023 Feb 14, 2024	BUY	$11.39 - $21.67 $2.88 Million - $5.48 Million	253,062 Added 115.86%	471,475 $10.2 Million
Q3 2023 Nov 14, 2023	SELL	$14.52 - $21.77 $292,636 - $438,752	-20,154 Reduced 8.45%	218,413 $3.17 Million
Q2 2023 Aug 14, 2023	BUY	$19.35 - $22.31 $1.76 Million - $2.03 Million	91,001 Added 61.67%	238,567 $4.99 Million
Q1 2023 May 15, 2023	BUY	$20.66 - $28.98 $2.86 Million - $4.01 Million	138,466 Added 1521.6%	147,566 $3.12 Million
Q4 2022 Feb 14, 2023	BUY	$20.64 - $26.24 $187,824 - $238,784	9,100 New	9,100 $231,000
Q1 2022 May 16, 2022	SELL	$14.84 - $22.15 $182,532 - $272,445	-12,300 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$15.23 - $22.47 $964,059 - $1.42 Million	-63,300 Reduced 83.73%	12,300 $269,000
Q3 2021 Nov 16, 2021	SELL	$13.87 - $19.8 $607,519 - $867,259	-43,801 Reduced 36.68%	75,600 $1.45 Million
Q2 2021 Aug 16, 2021	SELL	$13.42 - $25.18 $68,455 - $128,443	-5,101 Reduced 4.1%	119,401 $2.05 Million
Q1 2021 May 17, 2021	SELL	$19.28 - $24.59 $629,067 - $802,322	-32,628 Reduced 20.76%	124,502 $2.78 Million
Q4 2020 Feb 16, 2021	BUY	$15.1 - $26.44 $2.06 Million - $3.6 Million	136,314 Added 654.85%	157,130 $3.5 Million
Q3 2020 Nov 16, 2020	BUY	$13.39 - $17.48 $278,726 - $363,863	20,816 New	20,816 $0

Others Institutions Holding SNDX

# of Institutions

227

Shares Held

88.3M

Call Options Held

1.01M

Put Options Held

692K

View Full List

About Syndax Pharmaceuticals Inc

Ticker SNDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,565,200
Market Cap $910M
Description
Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...

More about SNDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.

Account

Schonfeld Strategic Advisors LLC Syndax Pharmaceuticals Inc Transaction History